Solvay licenses MediTECH to supply Zeniva PEEK shapes

Solvay licenses MediTECH to supply Zeniva PEEK shapes

October 21, 2019


MediTECH, a registered trademark of the Mitsubishi Chemical Advanced Materials group, announces a new licensing agreement with Solvay to fulfill customer orders for extruded stock shapes made with Solvay’s Zeniva PEEK. The agreement, which names MediTECH as Solvay’s licensee for the global fulfillment of Zeniva PEEK extruded shapes, will take effect immediately. The new licensing agreement expands MediTECH’s existing role in the longstanding partnership between the two companies, with the goal of bringing additional value to the customer channel.

Stock shapes produced from Zeniva PEEK, high-performance biocompatible polymers, are used primarily for orthopedic, cardiac and neurological implantable devices . Performance benefits of Zeniva PEEK shapes include biostability, high strength and stiffness, fatigue resistance and exceptional dimensional stability. These shapes are ideal for the close tolerance machining of finished components, and for prototypes used in injection molding applications. Additionally, Zeniva PEEK stock shapes have numerous advantages over metals, such as a reduction in stress shielding, no heavy metal allergy or ion erosion, and radiolucent properties which allow x-ray and CT scanning procedures to occur without interference.

“We are very excited to further our implantable shapes strategy with the addition of Zeniva PEEK, which complements our existing portfolio of UHMW implantable products. In conjunction with MediTECH’S unique “Near Net” manufacturing technology, we can provide customers with productivity improvements and a simplified supply chain” says Eric Tech, Global Market Manager for the Medical industry at Mitsubishi Chemical Advanced Materials. Matt Donahey, MediTECH’S Global Director, states that “As a global leader whose manufacturing facilities are certified under ISO 13485, MediTECH can also provide customers with deep expertise in regulatory, compliance, and supply chain management. For more than 30 years, Mitsubishi Chemical Advanced Materials' MediTECH Division has supplied leading orthopedic implantable device manufacturers with premium implantable-grade UHMW-PE under the Chirulen and Extrulen brand names.”

Jeff Hrivnak, Global Business Manager for Healthcare at Solvay’s Specialty Polymers global business unit adds, “This licensing agreement underscores our commitment to make it easier for customers to do business with Solvay and our partners. By reassigning fulfillment activities to MediTECH, our customers will also benefit from their deep expertise in regulatory requirements, as well as polymer shape technologies.”

Both companies- MediTECH and Solvay- are excited to enter into this new agreement that stems from a long history and partnership. Mitsubishi Chemical Advanced Materials has manufactured Solvay’s Zeniva PEEK shapes since the material’s inception 12 years ago. Zeniva PEEK resin and stock shapes comply with ISO 13485 manufacturing standards and meet current Good Manufacturing Practices (GMP). Based on rigorous biocompatibility testing, these products demonstrate no evidence of cytotoxicity, sensitization, irritation, or acute systemic toxicity as defined by ISO 10993. These products can be sterilized using all conventional methods, including gamma radiation, ethylene oxide, and steam.

**Mitsubishi Chemical Advanced Materials, formerly Quadrant EPP, was officially named on April 1st, 2019. The Quadrant Group was established in 2001 and acquired by Mitsubishi Chemical Corporation in 2013.